The Effect of Dexmedetomidine of the Immune System
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
The goal of this research study is to learn about how dexmedetomidine (a standard of care
sedative) affects your immune system (your defenses against cancer) by measuring your white
blood cell levels before and after surgery.
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborators:
Hospira, Inc. Hospira, now a wholly owned subsidiary of Pfizer